InvestorsHub Logo
Followers 3158
Posts 964210
Boards Moderated 197
Alias Born 09/04/2000

Re: mick post# 1399

Sunday, 10/25/2020 6:25:30 PM

Sunday, October 25, 2020 6:25:30 PM

Post# of 1635
ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Second-Generation COVID-19 Vaccine Candidate... Business Wire - 10/21/2020 5:06:00 PM
FDA Authorizes Phase 1 Trial of ImmunityBio’s Novel COVID-19 Vaccine Candidate hAd5; Dual Construct is Designed to Drive Bo... Business Wire - 10/15/2020 6:00:00 AM
NantKwest, ImmunityBio Add Third-Line Cohort to Phase 2 Pancreatic Cancer Trial; Opens Study to Patients Who Have Failed All ... Business Wire - 10/6/2020 4:05:00 PM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBRX News